Published online Jun 6, 2026. doi: 10.12998/wjcc.v14.i16.120049
Revised: April 3, 2026
Accepted: April 22, 2026
Published online: June 6, 2026
Processing time: 98 Days and 12.5 Hours
Mammary Paget’s disease, also known as Paget’s disease of the breast (PDB), is a rare malignancy of the nipple-areolar complex that is frequently associated with underlying ductal carcinoma in situ (DCIS) or invasive carcinoma. However, the underlying malignancy may remain occult on conventional imaging, potentially delaying diagnosis.
We report the case of a 75-year-old woman with a 2-year history of a persistent erythematous lesion of the right nipple, initially treated as eczema. Mammo
PDB may present as persistent unilateral nipple-areolar dermatitis with incon
Core Tip: Mammary Paget’s disease, also known as Paget’s disease of the breast, may present as chronic nipple eczema without a detectable underlying malignant lesion on conventional imaging. In this case, diagnosis required repeat biopsy and magnetic resonance imaging despite initially benign imaging findings. Clinicians should maintain a high index of suspicion and pursue histopathologic evaluation when unilateral nipple-areolar dermatitis persists, even in the absence of radiologic evidence of malignancy.
- Citation: Tsai CY, Lo TC, Yu JC, Hong ZJ, Sung YK. Paget’s disease of the nipple with occult ductal carcinoma in situ despite negative conventional imaging: A case report. World J Clin Cases 2026; 14(16): 120049
- URL: https://www.wjgnet.com/2307-8960/full/v14/i16/120049.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i16.120049
Mammary Paget’s disease, also known as Paget’s disease of the breast (PDB), is a rare non-invasive malignancy of the nipple-areolar complex that typically presents with erythema, ulceration, eczema-like changes, or nipple discharge. Nipple flattening is common, and retraction or inversion may indicate an underlying malignancy.
PDB primarily affects postmenopausal women, with a median age of onset of approximately 64 years, although cases in men have been reported. Up to 90% of patients have an associated underlying malignancy, most commonly ductal carcinoma in situ (DCIS) or invasive ductal carcinoma. Despite this strong association, PDB accounts for only about 1%-3% of all breast cancers[1].
Imaging plays a central role in evaluation. Mammography has high sensitivity when a palpable mass is present but is considerably less sensitive in non-palpable disease[2]. Magnetic resonance imaging (MRI) can detect additional occult or multifocal disease and is often used when conventional imaging is inconclusive[3]. Nevertheless, imaging alone may fail to detect an underlying malignancy, underscoring the importance of tissue diagnosis.
A 75-year-old woman presented with a persistent erythematous lesion of the right nipple accompanied by intermittent stabbing pain for 2 years.
The patient noted progressive erythema and intermittent lancinating pain of the right nipple over approximately 2 years. She reported no palpable breast mass or nipple discharge. The lesion was initially diagnosed as eczema at a local clinic and treated with topical corticosteroids without improvement.
Subsequent mammography demonstrated grouped calcifications without significant interval change compared with prior imaging. Breast ultrasonography showed cutaneous changes in the right nipple, raising suspicion for Paget’s disease. A skin biopsy confirmed Paget’s disease, with immunohistochemistry demonstrating equivocal estrogen receptor expression, progesterone receptor negativity, and HER2 overexpression (3+).
MRI revealed nipple inversion, skin thickening, and enhancement consistent with Paget’s disease but no definite underlying invasive mass. Based on these findings, the patient elected to undergo surgical management.
The patient had hypertension for 20 years, which was well controlled with medication.
The patient reported no family history of breast cancer or other malignancies.
The physical examination revealed an erythematous, ulcerative lesion involving the right nipple-areolar complex with crusting and irregular margins. No palpable mass, nipple discharge, skin dimpling, or axillary lymphadenopathy was identified. The contralateral breast was unremarkable (Figure 1).
Routine laboratory examinations, including complete blood count and biochemical tests, revealed no significant abnormalities.
Mammography demonstrated grouped punctate and amorphous calcifications (Figure 2) in the upper outer quadrant and retroareolar region of the right breast without associated mass, distortion, or axillary lymphadenopathy (Breast Imaging Reporting and Data System 0). Ultrasonography revealed small hypoechoic nodules (< 5 mm) consistent with benign changes and poorly visualized nipple abnormalities (Figure 3). Contrast-enhanced MRI showed nipple inversion with skin thickening and enhancement but no discrete mass (Figure 4A). Multiple small enhancing foci were present bil
Histological examination of the nipple biopsy showed malignant ductal epithelial cells infiltrating the epidermis, with characteristic Paget cells demonstrating high nuclear-to-cytoplasmic ratios, hyperchromatic nuclei, and cytokeratin 7 positivity (Figure 5).
Surgical pathology after partial mastectomy revealed high-grade multifocal DCIS with central necrosis and ductal expansion (Figure 6).
PDB with underlying high-grade multifocal DCIS.
The patient underwent central partial mastectomy with sentinel lymph node biopsy, followed by adjuvant radiotherapy.
The postoperative course was uneventful. The patient was discharged on postoperative day 1 and remains without evidence of recurrence on follow-up (Table 1).
| Time | Clinical events |
| November 2023 | Skin biopsy: Chronic inflammation with granulation tissue |
| October 2024 | Mammography: Grouped calcifications without significant changes compared to previous mammography in a local hospital |
| Breast ultrasonography: Cutaneous changes that raise suspicion for Paget’s disease | |
| Repeat skin biopsy: Confirmed Paget’s disease. Estrogen receptor equivocal staining, progesterone receptor-negative, HER2-positive (3+ 90% of cells) | |
| MRI: Right nipple inversion and enhancement with thickening of covering skin, compatible with Paget’s disease | |
| October 2024 | Surgery: Right breast central type partial mastectomy and sentinel node dissection |
| November 2024 | Pathology: Paget’s disease with high-grade multifocal ductal carcinoma in situ |
| November 2024 | Follow-up: Radiation therapy and outpatient department regular checkup, showing good recovery |
PDB presents a well-recognized diagnostic challenge because the associated intraductal carcinoma is frequently radiologically occult. In this case, mammography, ultrasonography, and MRI demonstrated superficial changes consistent with Paget’s disease but failed to identify the underlying high-grade multifocal DCIS, which was only detected on postoperative pathology. This discordance underscores a key clinical limitation: Imaging may underestimate or entirely miss clinically significant disease in PDB.
Previous studies have demonstrated that conventional imaging has limited sensitivity in non-palpable PDB. Mammography detects an underlying malignancy in only 30%-50% of cases when no palpable mass is present, particularly when DCIS lacks calcifications or is confined to the superficial retroareolar ductal system[2,4]. Even when abnormalities are identified, mammography may underestimate the true extent of disease. Ultrasonography shows similar variable performance, with reported sensitivities ranging from 8%-50%, largely because DCIS often presents as non-mass abnormalities that overlap with benign ductal or fibrocystic changes[5,6]. Studies reported that approximately 65% of patients have an underlying malignancy that is not apparent on mammography[5,6]. Likewise, Ikeda et al[7] found that mammography appears normal in 29%-50% of Paget’s disease cases and, when positive, often underestimates the extent of the underlying malignancy.
The diagnostic challenge of imaging-negative DCIS reflects the complex pathophysiology of intraductal malignancies. Although up to 75% of DCIS cases present as suspicious microcalcifications on mammography, their detectability depends on both their chemical composition and the underlying biological process of mineral deposition. Calcium phosphate (particularly hydroxyapatite) is often associated with malignancy but may be radiographically indistinguishable from benign calcium oxalate. Moreover, calcification formation results from a combination of active secretory processes and passive degeneration, which may not occur even in high-grade lesions. In the absence of characteristic fine linear branching or pleomorphic morphologies, DCIS may remain mammographically occult[8].
Similarly, the limited sensitivity of ultrasonography (8%-50%) for DCIS is largely attributable to the fact that more than 60% of cases present as non-mass abnormalities, such as subtle hypoechoic areas or minor ductal changes, that overlap with benign duct ectasia[8]. In this patient, the confinement of malignant cells to the superficial ducts, without formation of a discrete mass or significant calcification, likely fell below the spatial resolution of conventional imaging, resulting in a deceptively reassuring radiological appearance despite the presence of high-grade disease.
MRI plays a crucial role in the presurgical evaluation of Paget’s disease of the nipple, particularly when mammography and ultrasound are negative. Contrast-enhanced MRI can identify edema of the nipple-areolar complex, skin thickening, retroareolar masses, ductal dilatation, and parenchymal enhancement; it also provides superior sensitivity in distinguishing normal from abnormal nipple-areolar morphology, particularly when the disease is confined to the epidermis without underlying invasive carcinoma[2].
Although MRI is the most sensitive modality for detecting occult breast malignancy, its performance in identifying DCIS associated with Paget’s disease remains variable. Enhancement patterns of DCIS may be subtle or heterogeneous, and recent studies indicate that MRI detects only a subset of occult DCIS cases in this setting[9]. Trebska-McGowan et al[10] reported that the sensitivity of MRI for DCIS decreases to 44%, whereas it approaches 100% for invasive carcinoma.
Given that PDB is associated with an underlying malignancy in up to 90% of cases, a high index of clinical suspicion is essential. Persistent nipple-areolar skin lesions, particularly those that mimic inflammatory conditions such as eczema, should prompt early skin biopsy and comprehensive breast imaging to enable timely diagnosis. Although PDB often follows an indolent course, delays in diagnosis may allow progression to a high-grade, multifocal disease, as illustrated in this case. Earlier biopsy at symptom onset might have identified the disease at a more localized stage, potentially simplifying surgical management and improving outcomes. Early detection remains critical for the effective management of occult malignancy in Paget’s disease.
This case highlights a critical clinical principle: The absence of suspicious findings on conventional imaging does not exclude a significant underlying malignancy in patients with suspected Paget’s disease. Clinicians should prioritize histopathologic evaluation over reassuring radiologic findings. Persistent unilateral nipple dermatitis warrants biopsy, even when appearance is benign on imaging.
The authors would like to thank the radiology and pathology teams for their contributions to the diagnostic evaluation of this case.
| 1. | Bulens P, Vanuytsel L, Rijnders A, van der Schueren E. Breast conserving treatment of Paget's disease. Radiother Oncol. 1990;17:305-309. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 32] [Cited by in RCA: 31] [Article Influence: 0.9] [Reference Citation Analysis (0)] |
| 2. | Lim HS, Jeong SJ, Lee JS, Park MH, Kim JW, Shin SS, Park JG, Kang HK. Paget disease of the breast: mammographic, US, and MR imaging findings with pathologic correlation. Radiographics. 2011;31:1973-1987. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 50] [Cited by in RCA: 63] [Article Influence: 4.5] [Reference Citation Analysis (0)] |
| 3. | Sisti A, Huayllani MT, Restrepo DJ, Boczar D, Advani P, Lu X, Spaulding AC, Ball CT, McLaughlin SA, Forte AJ. Paget disease of the breast: A national retrospective analysis of the US population. Breast Dis. 2020;39:119-126. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 4] [Cited by in RCA: 10] [Article Influence: 1.7] [Reference Citation Analysis (0)] |
| 4. | Markarian S, Holmes DR. Mammary Paget's Disease: An Update. Cancers (Basel). 2022;14:2422. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1] [Cited by in RCA: 23] [Article Influence: 5.8] [Reference Citation Analysis (0)] |
| 5. | Morrogh M, Morris EA, Liberman L, Van Zee K, Cody HS 3rd, King TA. MRI identifies otherwise occult disease in select patients with Paget disease of the nipple. J Am Coll Surg. 2008;206:316-321. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 52] [Cited by in RCA: 47] [Article Influence: 2.6] [Reference Citation Analysis (0)] |
| 6. | Yadav P, Koppal D. Imaging in Paget disease of breast. Indian J Breast Imaging. 2025;3:39-46. [DOI] [Full Text] |
| 7. | Ikeda DM, Helvie MA, Frank TS, Chapel KL, Andersson IT. Paget disease of the nipple: radiologic-pathologic correlation. Radiology. 1993;189:89-94. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 53] [Cited by in RCA: 43] [Article Influence: 1.3] [Reference Citation Analysis (0)] |
| 8. | Shehata M, Grimm L, Ballantyne N, Lourenco A, Demello LR, Kilgore MR, Rahbar H. Ductal Carcinoma in Situ: Current Concepts in Biology, Imaging, and Treatment. J Breast Imaging. 2019;1:166-176. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 20] [Cited by in RCA: 37] [Article Influence: 5.3] [Reference Citation Analysis (0)] |
| 9. | Oba T, Maeno K, Iji R, Kiyosawa N, Park Y, Morikawa H, Amitani M, Shimizu T, Ono M, Ito T, Kanai T, Matoba H, Takayama F, Ito KI. Utility of contrast-enhanced magnetic resonance imaging for planning of surgical procedure in Paget's disease of the breast. Surg Today. 2025;55:778-786. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1] [Cited by in RCA: 2] [Article Influence: 2.0] [Reference Citation Analysis (0)] |
| 10. | Trebska-McGowan K, Terracina KP, Takabe K. Update on the surgical management of Paget's disease. Gland Surg. 2013;2:137-142. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 5] [Reference Citation Analysis (0)] |